Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease

Chronic graft-versus-host disease (cGVHD) remains a frequent cause of non-relapse morbidity and mortality after allogeneic hematopoietic stem cell transplantation. In our single center trials of low-dose interleukin-2 (LD IL-2), the immunomodulatory properties of regulatory T cells (Tregs) have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Donato, Veronica, Kim, Haesook T., Stowe, Peter, Reynolds, Carol G., Ritz, Jerome, Koreth, John, Whangbo, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515381/
https://www.ncbi.nlm.nih.gov/pubmed/36189229
http://dx.doi.org/10.3389/fimmu.2022.954966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515381/
https://www.ncbi.nlm.nih.gov/pubmed/36189229
http://dx.doi.org/10.3389/fimmu.2022.954966

Ejemplares similares